Congressional Record—Senate S1132
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Public Version Filed: February 14, 2019
EFiled: Feb 14 2019 05:12PM EST Transaction ID 62972723 Case No. 2018-0740-SG IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE IN RE OPKO HEALTH, INC. ) Consol. C.A. No. 2018-0740-SG DERIVATIVE ACTION ) CONFIDENTIAL FILING VERIFIED CONSOLIDATED DERIVATIVE COMPLAINT Court-appointed Co-Lead Plaintiffs Jamie Gewirtz, Emily Gewirtz Stiebel, Richard Tunick, Esther Susan Lutzker, and Vivian Davis, and additional plaintiffs Ivan Pawlenko and Martin Breuninger (collectively, "Plaintiffs"), by their attorneys, allege upon personal knowledge as to their own acts and upon information and belief as to all other matters, based upon the investigation conducted by counsel, which included, inter alia, review and analysis of: (a) internal, non-public documents provided by OPKO Health, Inc. ("OPKO or "Company") in response to demands under 8 Del. C. §220; (b) the public filings of OPKO and related non-parties with the U.S. Securities and Exchange Commission ("SEC"); (c) press releases and other public statements disseminated or caused to be made or issued by defendants and related non-parties; (d) media reports concerning the Company; (e) the Complaint and related filings in the action filed by the SEC on September 7, 2018 in the United States District Court for the Southern District of New York, captioned SEC v. Honig, et al., 18-cv-8175, charging a number of entities and persons, including OPKO and its Chief Executive Officer ("CEO") and Chairman of the Board, Phillip Frost ("Frost"), with violations of the federal securities laws (the "SEC Action"); and (f) other publicly available information, as follows: NATURE AND SUMMARY OF THE ACTION 1. -
United States District Court Southern District Of
Case 1:18-cv-24137-XXXX Document 1 Entered on FLSD Docket 10/08/2018 Page 1 of 33 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF FLORIDA CIVIL ACTION NO. 1:18cv24137 PAUL CAMHI, Individually and on Behalf of ) CLASS ACTION All Others Similarly Situated, ) ) Plaintiff, ) ) vs. ) ) OPKO HEALTH, INC. and PHILLIP FROST, ) ) Defendants. ) ) DEMAND FOR JURY TRIAL COMPLAINT FOR VIOLATIONS OF THE FEDERAL SECURITIES LAWS Case 1:18-cv-24137-XXXX Document 1 Entered on FLSD Docket 10/08/2018 Page 2 of 33 Plaintiff Paul Camhi (“plaintiff”) alleges the following based upon the investigation of plaintiff’s counsel, which included a review of U.S. Securities and Exchange Commission (“SEC”) filings by OPKO Health, Inc. (“Opko” or the “Company”), as well as regulatory filings and reports, securities analysts’ reports and advisories about the Company, press releases and other public statements issued by the Company, media reports about the Company, and the complaint in the enforcement action filed by the SEC, SEC vs. Honig, No. 18-cv-08175 (S.D.N.Y. Sept. 7, 2018) (the “SEC Complaint”) as detailed herein. Plaintiff believes that substantial additional evidentiary support will exist for the allegations set forth herein after a reasonable opportunity for discovery. NATURE OF THE ACTION 1. This is a securities class action on behalf of all purchasers of Opko common stock between October 8, 2013 and September 7, 2018, inclusive (the “Class Period”) seeking to pursue remedies under the Securities Exchange Act of 1934 (“1934 Act”). JURISDICTION AND VENUE 2. The claims asserted herein arise under and pursuant to §§10(b) and 20(a) of the 1934 Act (15 U.S.C. -
Opko Health: the Placebo Effect
Opko Health: The Placebo Effect Lakewood Capital Management December 2013 /placebo effect/ (plah-se’bo ĕ-fekt’), noun [L.]: 1. the beneficial effect that occurs following a treatment administered to a group that arises simply from that group’s faith or preconceptions that the treatment will work. 2. an ineffectual treatment intended to deceive the recipient. Table of Contents A.) Executive Summary ................................................................................................... 1 B.) A Dizzying History Of Deals and Disappointment .................................................. 8 C.) Poor Financial Results… Yet A Soaring Market Capitalization ............................. 15 D.) Latin American Drug Distribution ........................................................................... 17 E.) Exploratory Alzheimer’s Diagnostic ...................................................................... 18 F.) Claros Diagnostics ................................................................................................... 19 G.) 4Kscore™ Exploratory Prostate Cancer Screening Test ......................................... 22 H.) Rayaldy .................................................................................................................... 26 I.) Prolor Biotech .......................................................................................................... 30 J.) A Web Of Stock Promotion ..................................................................................... 33 K.) Insider Share Purchases -
Miller School Celebrates the Naming of the Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery
Julie Levin March 27, 2019 Miller School Celebrates the Naming of the Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery After slipping on crisp, new white lab coats, Dr. Phillip and Patricia Frost formally launched a new era for the University of Miami Leonard M. Miller School of Medicine’s prestigious Department of Dermatology. The lab coats featured a new name and logo – the Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery – a symbol of the tremendous impact the renowned South Florida philanthropist and physician has had on the department throughout its storied history. https://physician-news.umiamihealth.org/miller-school-celebrates-the-naming-of-the-dr-phillip-frost-department-of-dermatology-and-cutaneous-surgery/ 1 / 6 Julie Levin March 27, 2019 Dr. Phillip and Patricia Frost put on new lab coats with the logo of the Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery. Thanks to the Frosts’ generosity, the department will receive a $10 million endowment, which will help advance innovative treatments and cures in dermatology. The gift celebrates Dr. Frost’s lifetime of dedication to medicine, education, and medical entrepreneurship. “We hope this gift commemorates the debt that we feel to not only the department, school, and the city, but it makes us feel as though we will have a stake in its future,” said Dr. Frost, who spoke alongside his wife, Patricia, at a March 6 naming ceremony at the Miller School. https://physician-news.umiamihealth.org/miller-school-celebrates-the-naming-of-the-dr-phillip-frost-department-of-dermatology-and-cutaneous-surgery/ 2 / 6 Julie Levin March 27, 2019 One of the earliest departments founded at the Miller School, the Dr. -
Winter/Spring 2011PDF Only
WINTER/SPRING 2011 EINSTThe Magazine for Alumni and Friends of Albert Einstein CollegeE of Medicine ofIN Yeshiva University DE[LIVER]ANCE Researchers and Clinicians Team Up to Combat the Liver Disease Epidemic Meet Our Interactive Companion Magazine Get ready for Einstein magazine’s “virtual” debut! This interactive version of the magazine resides at www.einstein.yu.edu/epubs/einstein/winterspring2011 and adds voices and moving images to the text and pictures you now hold in your hands. You’ll be able to hear interviews with Einstein faculty members, see how Einstein and Montefiore researchers are working to defeat liver disease ... and more. If you like the status quo, don’t worry: We’ll continue to publish Einstein magazine in print form. But do please give our alternative format a try as well. And let us know what you think about it by sending us a note at [email protected]. Follow Us on 2 EINSTEIN : WINTER/SPRING 2 011 EinsteinMagazineWinterSpringFINAL5_17_11—July 28, 2011 6:50 PM WINTER/SPRING 2011 in this issue FEATURES 2 A MESSAGE FROM THE DEAN 22 DE[LIVER]ANCE Scientists at Einstein and Montefiore are joining forces against the liver disease epidemic 22 30 SPOTLIGHT ON: PHILLIP FROST, M.D., CLASS OF 1961 As the Einstein graduating class of 1961 prepares for its 50th Reunion, we focus on one of its most notable members 32 SERVING CHILDREN AND ADULTS aT CERC Einstein’s Children’s Evaluation and Rehabilitation Center serves thousands of infants, children, adoles- 40 cents and adults each year 40 RENOVATING VaN ETTEN Einstein’s new “Main Street” gets a makeover DEPARTMENTS 3 Letters to the Editor on the cover 4 Upfront: Collegial Life Researchers and physicians from Albert Einstein College of Medicine and Montefiore Medical Center, the 13 Upfront: Lab Dish University Hospital and Academic Medical Center for Einstein, are working together to bring state-of-the-art 44 Passionate Pursuits therapies to liver disease patients. -
The Patricia & Phillip Frost Art Museum Florida International
The Patricia & Phillip Frost Art Museum Florida International University 2017-2018 Annual Report Table of Contents 1. From the Director 2. Exhibitions 3. Changes to the Collection 4. Grants 5. Education & Outreach 6. Academic Programming & Strategic Initiatives 7. Public Relations 8. Facilities 9. Development 10. Statement of Operations Cover Image Caption: Carlene West, Pitjantjatjara, born c. 1944 Tjitjiti [detail], 2015, 71 13/20 x 47 16/25 inches, © the artist, courtesy Spinifex Arts Project. From the exhibition Marking the Infinite: jfkdsfjsdklf, on view at the Frost from January 28, 2017 to May 14, 2017 th 10 Anniversary Message from the Director In 2008 the Patricia & Phillip Frost Art Museum opened its doors to invite students, faculty, Miami-Dade citizens, and the international art world to enjoy a new museum experience in Miami. The 46,000-square-foot building featured grand galleries with cathedral-like ceilings as well as an interactive children’s area. The inaugural exhibition Modern Masters from the Smithsonian American Art Museum showed work of 1940’s and 50’s abstract expressionists including Hans Hofmann, Franz Kline, and Louise Nevelson, among others. In 2018 we welcome you to the Patricia & Phillip Frost Art Museum as we unveil the museum’s growing collection of art and peek into the museum’s vibrant history. In 1972, Florida International University opened its doors to the first class of South Florida students. The newly emerging FIU Fine Arts Department was in desperate need of a space for students and faculty members to showcase their work and, more importantly, an art space for the community. -
1 United States District Court Southern District Of
Case 1:21-cv-20885-CMA Document 1 Entered on FLSD Docket 03/05/2021 Page 1 of 86 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF FLORIDA SAMMY LEE, derivatively on behalf of OPKO HEALTH, INC., Plaintiff, C.A. No. v. PHILLIP FROST, ADAM LOGAL, JANE H. DEMAND FOR JURY TRIAL HSIAO, STEVEN D. RUBIN, ROBERT S. FISHEL, RICHARD M. KRASNO, RICHARD A. LERNER, JOHN A. PAGANELLI, RICHARD C. PFENNIGER, JR., and ALICE LIN-TSING YU, Defendants, and OPKO HEALTH, INC., Nominal Defendant. VERIFIED SHAREHOLDER DERIVATIVE COMPLAINT INTRODUCTION Plaintiff Sammy Lee (“Plaintiff”), by Plaintiff’s undersigned attorneys, derivatively and on behalf of Nominal Defendant OPKO Health, Inc. (“OPKO” or the “Company”) files this Verified Shareholder Derivative Complaint against Individual Defendants Phillip Frost (“Frost”), Adam Logal (“Logal”), Jane H. Hsiao (“Hsiao”), Steven D. Rubin (“Rubin”), Robert S. Fishel (“Fishel”), Richard M. Krasno (“Krasno”), Richard A. Lerner (“Lerner”), John A. Paganelli (“Paganelli”), Richard C. Pfenniger, Jr. (“Pfenniger”), and Alice Lin-Tsing Yu (“Yu”), (collectively, the “Individual Defendants” and together with OPKO, the “Defendants”) for breaches of their fiduciary duties as controlling shareholders, directors and/or officers of OPKO, unjust enrichment, waste of corporate assets, abuse of control, gross mismanagement, and violations of Section 14(a) 1 Case 1:21-cv-20885-CMA Document 1 Entered on FLSD Docket 03/05/2021 Page 2 of 86 of the Securities Exchange Act of 1934 (the “Exchange Act”). As for Plaintiff’s complaint against